Reducing Kidney Disease Risk with Ozempic 1 mg Semaglutide
Ozempic 1mg semaglutide has emerged as a game-changer in the management of kidney disease in diabetes patients. The medication has shown remarkable efficacy in reducing kidney disease progression, major adverse cardiovascular events, and deaths. The SELECT Trial: A Landmark Study The SELECT trial, released last year, demonstrated that semaglutide significantly reduced rates of hard cardiovascular…